HUNTINGTON'S DISEASE TESTING

Every Huntington's risk gene, one test to know.

Whole genome sequencing evaluates the HTT gene — alongside your entire genome. One clinical-grade test, processed in accredited laboratories, with results that meet the standard your neurologist and genetic counselor require.

CLIA Certified CAP Accredited ISO 15189 Medical Lab ACMG Classified HIPAA & GDPR 100,000+ Genomes Sequenced
As seen in & research partnerships
CNN CNBC Financial Times NVIDIA AWS Nature ASHG HIMSS
THE CLINICAL ADVANTAGE

Standard genetic tests miss 99.98% of your DNA. Dante reads all of it — so nothing clinically relevant goes unseen.

WHAT'S INCLUDED

A lifetime of clinical insights from a single test.

Get actionable genetic reports. User friendly portal organized by clinical area. 30X Genome Test. Full data ownership and privacy protection.

genome.danteomics.com
Physician-ready clinical report: Autoimmune Disease Report overview with variant table
Genome Manager dashboard with featured reports and raw data downloads
Genetic findings view showing variant detail from 30X clinical sequencing
ACMG Assertion Criteria — pathogenic and benign classification evidence

200+ Physician-Ready Reports

Comprehensive reporting across cardiology, oncology, rare disease, neurological conditions, and pharmacogenomics — designed to share directly with your specialist, and continually updated for life as science advances.

Secure Genome Manager

A HIPAA and GDPR-compliant portal with lifelong access to your complete clinical insights, new report releases as science advances, and specialist referral guidance.

30X Clinical Sequencing

Your entire genome sequenced at 30X coverage — the standard required for clinical-grade diagnosis. Every one of your 6.4 billion letters, read.

Full Data Ownership & Privacy

Unrestricted access to your BAM, VCF, and FASTQ files. Your genetic data belongs to you — export it to any independent specialist, at any time, forever.

Dante's secure data architecture was built across multiple, independent GDPR and HIPAA-compliant data protection layers. Your data is never shared with insurers, pharmaceutical companies, or research programs without your explicit consent. You can request deletion at any time.

Full data and privacy policy →
OUTCOMES

The results doctors bring to their hardest cases.

"You save lives." — Dante Labs customer

Forty years of uncertainty. One test.

A patient had spent decades in the UK healthcare system without a diagnosis. Dante data, accepted by NHS clinical teams at Queen Elizabeth University Hospital Glasgow, identified Noonan Syndrome and a RUNX1 leukemia-associated variant that had gone undetected. After 40 years, they finally had an answer.

A complete read delivers a complete picture.

A patient came to Dante to investigate periodic paralysis. Reading the complete genome identified a concurrent hereditary cardiac finding — Brugada syndrome — that their doctor confirmed with an ECG. The result also explained a family member's unresolved cardiac history. One test. Every answer in it.

Sequenced in 2019. The data worked in 2021.

Jennifer sequenced her genome with Dante two years before her breast cancer diagnosis. When treatment began, Dante's pharmacogenomics data showed her prescribed chemotherapy would cause serious adverse effects based on her genetic profile. Her doctor selected an alternative — and she started effective treatment from day one.

Accredited by & published in

Clinical Laboratory Improvement Amendments College of American Pathologists American Society of Human Genetics Nature International Society for Cell & Gene Therapy Gene Journal
COMMON QUESTIONS

What you need to know before ordering.

The test evaluates the HTT gene, including the CAG trinucleotide repeat expansion that causes Huntington's disease. A normal repeat count is typically 26 or fewer; 36 or more repeats is associated with developing HD. Whole genome sequencing evaluates this alongside your full genome, providing a complete genetic picture in a single test.

Whole genome sequencing results are typically delivered in 6–8 weeks once your sample arrives at the lab. You'll receive status updates by email at each step of the process.

Yes. Professional guidelines strongly recommend genetic counseling before and after predictive testing for Huntington's disease. A genetic counselor can help you understand the implications of testing, prepare for possible outcomes, and support you in using the results. Dante's clinical reports are designed to be shared directly with your genetic counselor and neurologist.

In the United States, the Genetic Information Nondiscrimination Act (GINA) prohibits health insurers and employers from using genetic test results against you. GINA does not cover life, disability, or long-term care insurance. Laws vary by state and country. Dante does not share your genetic data with any third party — including insurers — without your explicit consent. You own your data and can delete it at any time.

When you're ready, the answer is here.

One kit, sent to your home. Your entire genome sequenced at the clinical standard used for diagnostic decisions. 200+ physician-ready reports delivered to your Genome Manager in 6–8 weeks — permanent and updated as science advances. Your raw data — BAM, VCF, and FASTQ — downloadable at any time, forever yours.

Free global shipping
Ships within 48 hours
Results in 6–8 weeks

Free global shipping · Results in 6–8 weeks

Dante Labs Genome Test Kit